Blog

Latest Researchers Blog

Immunity Double Edged Sword - Sanguine Biosciences Inc.

Immunity’s Double-Edged Sword

October 28, 2022

Finding the perfect samples to understand epidemics and pandemics, past…

TBNK cells - Sanguine Biosciences Inc.

TBNK cells: What are They and What Can They Tell Us?

September 19, 2022

Only about 1% of the blood is made up white…

Serum vs. Plasma - Sanguine Biosciences Inc.

Serum vs. Plasma: What to Use for Your Research?

August 25, 2022

Serum vs. Plasma: What to use for your research? Blood…

Building on the Power of Purpose - Sanguine Biosciences Inc.

Fortune Best Small Workplaces – #30 out of 100 in the US

August 11, 2022

Building on the Power of Purpose Sanguine Biosciences leverages employee…

Trends in Biospecimen Collection - Sanguine Biosciences Inc.

Trends in Biospecimen Collection

June 14, 2022

The use of biospecimens in clinical research is integral to…

Accelerating Clinical Development - Sanguine Biosciences Inc.

Accelerating Translational Research Programs and Reducing Costs

June 13, 2022

Sanguine’s patient-led approach and operational experience has allowed us to…

The History of Transplants - Sanguine Biosciences Inc.

The History of Transplants and How Xenotransplantation can be Used to Save Human Lives

June 6, 2022

A kidney transplant was the first human organ transplant to…

chickoregg - Sanguine Biosciences Inc.

Chicken-or-Egg Paradox Sheds Light on Genetic Variants

May 20, 2022

The dilemma of untangling cause and effect is perhaps best…

CTCs and Indicators in Cancer - Sanguine Biosciences Inc.

Circulating Tumor Cells and Indicators in Cancer

April 27, 2022

What are circulating tumor cells? Circulating tumor cells (CTCs) are…